• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C/EBPα 通过独特的双模态相互作用重定向雄激素受体信号。

C/EBPalpha redirects androgen receptor signaling through a unique bimodal interaction.

机构信息

Department of Biochemistry and Cancer Biology, Medical University of Ohio, Toledo, OH 43614, USA.

出版信息

Oncogene. 2010 Feb 4;29(5):723-38. doi: 10.1038/onc.2009.373. Epub 2009 Nov 9.

DOI:10.1038/onc.2009.373
PMID:19901962
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3836216/
Abstract

Nuclear expression of CCAAT enhancer binding protein-alpha (C/EBPalpha), which supports tissue differentiation through several antiproliferative protein-protein interactions, augurs terminal differentiation of prostate epithelial cells. C/EBPalpha is also a tumor suppressor, but in many tumors its antiproliferative interactions may be attenuated by de-phosphorylation. C/EBPalpha acts as a corepressor of the classical androgen response element (ARE)-mediated gene activation by the androgen receptor (AR), but this is paradoxical as the genotropic actions of AR are crucial not only for the growth of the prostate but also for its maintenance and function. We show that DNA-bound C/EPBalpha recruits AR to activate transcription. C/EBPalpha-dependent trans-activation by AR also overrode suppression of AREs by C/EBPalpha elsewhere in a promoter. This mechanism was remarkable in that its androgen dependence was apparently for nuclear translocation of AR; it was otherwise androgen independent, flutamide insensitive and tolerant to disruption of AR dimerization. Gene response profiles and global chromatin associations in situ supported the direct bimodal regulation of AR transcriptional signaling by C/EBPalpha. This unique mechanism explains the functional coordination between AR and C/EPBalpha in the prostate and also shows that hormone-refractory AR signaling in prostate cancer could occur through receptor tethering.

摘要

CCAAT 增强子结合蛋白-α(C/EBPα)的核表达支持通过几种抗增殖蛋白-蛋白相互作用的组织分化,预示着前列腺上皮细胞的终末分化。C/EBPα 也是一种肿瘤抑制因子,但在许多肿瘤中,其抗增殖相互作用可能会因去磷酸化而减弱。C/EBPα 作为雄激素受体(AR)介导的经典雄激素反应元件(ARE)介导的基因激活的核心抑制剂,但这是矛盾的,因为 AR 的基因作用不仅对前列腺的生长至关重要,而且对其维持和功能也至关重要。我们表明,与 DNA 结合的 C/EBPα 招募 AR 来激活转录。AR 的 C/EBPα 依赖性转录激活也克服了 C/EBPα 在启动子其他部位对 ARE 的抑制。这种机制非常显著,因为它的雄激素依赖性显然是 AR 的核易位;否则,它与雄激素无关,对氟他胺不敏感,并且能够耐受 AR 二聚化的破坏。基因反应谱和原位全染色质关联支持 C/EBPα 对 AR 转录信号的直接双模态调节。这种独特的机制解释了 AR 和 C/EBPα 在前列腺中的功能协调,也表明前列腺癌中激素难治性 AR 信号可能通过受体固定发生。

相似文献

1
C/EBPalpha redirects androgen receptor signaling through a unique bimodal interaction.C/EBPα 通过独特的双模态相互作用重定向雄激素受体信号。
Oncogene. 2010 Feb 4;29(5):723-38. doi: 10.1038/onc.2009.373. Epub 2009 Nov 9.
2
The CCAAT enhancer-binding protein-alpha negatively regulates the transactivation of androgen receptor in prostate cancer cells.CCAAT增强子结合蛋白α负向调节前列腺癌细胞中雄激素受体的反式激活。
Mol Endocrinol. 2006 May;20(5):984-95. doi: 10.1210/me.2005-0240. Epub 2006 Feb 2.
3
Expression and sub-cellular localization of the CCAAT/enhancer binding protein alpha in relation to postnatal development and malignancy of the prostate.CCAAT/增强子结合蛋白α在前列腺产后发育及恶性肿瘤中的表达与亚细胞定位
Prostate. 2008 Aug 1;68(11):1206-14. doi: 10.1002/pros.20779.
4
Regulation of heat shock protein 70-1 expression by androgen receptor and its signaling in human prostate cancer cells.雄激素受体及其信号通路对人前列腺癌细胞热休克蛋白 70-1 表达的调控。
Int J Oncol. 2010 Feb;36(2):459-67.
5
Down regulation of PSA by C/EBPalpha is associated with loss of AR expression and inhibition of PSA promoter activity in the LNCaP cell line.在LNCaP细胞系中,C/EBPα对前列腺特异性抗原(PSA)的下调与雄激素受体(AR)表达缺失及PSA启动子活性受抑制有关。
BMC Cancer. 2006 Jun 14;6:158. doi: 10.1186/1471-2407-6-158.
6
Modulation of androgen receptor transactivation by FoxH1. A newly identified androgen receptor corepressor.FoxH1对雄激素受体反式激活的调节。一种新发现的雄激素受体共抑制因子。
J Biol Chem. 2005 Oct 28;280(43):36355-63. doi: 10.1074/jbc.M506147200. Epub 2005 Aug 23.
7
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells.刺猬/ Gli 支持去势和去势抵抗性前列腺癌细胞中的雄激素信号。
Mol Cancer. 2010 Apr 26;9:89. doi: 10.1186/1476-4598-9-89.
8
c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.c-Jun增强雄激素受体反式激活与前列腺癌细胞增殖相关。
Oncogene. 2006 Nov 16;25(54):7212-23. doi: 10.1038/sj.onc.1209705. Epub 2006 May 29.
9
Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81.ETS变异体1/ETS相关蛋白81诱导前列腺上皮内瘤变及调节雄激素受体
Cancer Res. 2009 Oct 15;69(20):8102-10. doi: 10.1158/0008-5472.CAN-09-0941. Epub 2009 Sep 29.
10
Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.雄激素受体作为 ZEB2 表达的调节剂及其在前列腺癌上皮间质转化中的意义。
Endocr Relat Cancer. 2014 May 8;21(3):473-86. doi: 10.1530/ERC-13-0514. Print 2014 Jun.

引用本文的文献

1
Mutant androgen receptor induces neurite loss and senescence independently of ARE binding in a neuronal model of SBMA.突变雄激素受体在 SBMA 的神经元模型中独立于 ARE 结合诱导轴突损失和衰老。
Proc Natl Acad Sci U S A. 2024 Jul 16;121(29):e2321408121. doi: 10.1073/pnas.2321408121. Epub 2024 Jul 8.
2
Androgen-regulated stromal complement component 7 (C7) suppresses prostate cancer growth.雄激素调节的基质补体成分 7(C7)抑制前列腺癌生长。
Oncogene. 2023 Aug;42(32):2428-2438. doi: 10.1038/s41388-023-02759-7. Epub 2023 Jul 3.
3
Exosomes of pasteurized milk: potential pathogens of Western diseases.

本文引用的文献

1
Expression and sub-cellular localization of the CCAAT/enhancer binding protein alpha in relation to postnatal development and malignancy of the prostate.CCAAT/增强子结合蛋白α在前列腺产后发育及恶性肿瘤中的表达与亚细胞定位
Prostate. 2008 Aug 1;68(11):1206-14. doi: 10.1002/pros.20779.
2
A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth.一个转录因子的层级网络控制着雄激素受体依赖性前列腺癌的生长。
Mol Cell. 2007 Aug 3;27(3):380-92. doi: 10.1016/j.molcel.2007.05.041.
3
Genetic ablation of CCAAT/enhancer binding protein alpha in epidermis reveals its role in suppression of epithelial tumorigenesis.
巴氏消毒奶中的外泌体:西方疾病的潜在病原体。
J Transl Med. 2019 Jan 3;17(1):3. doi: 10.1186/s12967-018-1760-8.
4
Strategy for Tumor-Selective Disruption of Androgen Receptor Function in the Spectrum of Prostate Cancer.在前列腺癌谱中肿瘤选择性破坏雄激素受体功能的策略。
Clin Cancer Res. 2018 Dec 15;24(24):6509-6522. doi: 10.1158/1078-0432.CCR-18-0982. Epub 2018 Sep 5.
5
The miR-96 and RARγ signaling axis governs androgen signaling and prostate cancer progression.miR-96 和 RARγ 信号轴调控雄激素信号和前列腺癌进展。
Oncogene. 2019 Jan;38(3):421-444. doi: 10.1038/s41388-018-0450-6. Epub 2018 Aug 17.
6
Reduced expression of C/EBPβ-LIP extends health and lifespan in mice.C/EBPβ-LIP 表达减少可延长小鼠的健康和寿命。
Elife. 2018 Jun 4;7:e34985. doi: 10.7554/eLife.34985.
7
Integrative molecular network analysis identifies emergent enzalutamide resistance mechanisms in prostate cancer.整合分子网络分析确定前列腺癌中出现的恩杂鲁胺耐药机制。
Oncotarget. 2017 Nov 20;8(67):111084-111095. doi: 10.18632/oncotarget.22560. eCollection 2017 Dec 19.
8
Inherited determinants of early recurrent somatic mutations in prostate cancer.前列腺癌早期复发性体细胞突变的遗传决定因素。
Nat Commun. 2017 Jun 29;8(1):48. doi: 10.1038/s41467-017-00046-0.
9
Retinoic acid-related orphan receptor alpha (RORA) variants are associated with autism spectrum disorder.视黄酸相关孤儿受体α(RORA)变体与自闭症谱系障碍有关。
Metab Brain Dis. 2017 Oct;32(5):1595-1601. doi: 10.1007/s11011-017-0049-6. Epub 2017 Jun 12.
10
A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood.C/EBPα在实体瘤中的肿瘤抑制作用:不止于脂肪和血液。
Oncogene. 2017 Sep 14;36(37):5221-5230. doi: 10.1038/onc.2017.151. Epub 2017 May 15.
表皮中CCAAT/增强子结合蛋白α的基因消融揭示了其在抑制上皮肿瘤发生中的作用。
Cancer Res. 2007 Jul 15;67(14):6768-76. doi: 10.1158/0008-5472.CAN-07-0139.
4
Trawler: de novo regulatory motif discovery pipeline for chromatin immunoprecipitation.Trawler:用于染色质免疫沉淀的从头调节基序发现流程
Nat Methods. 2007 Jul;4(7):563-5. doi: 10.1038/nmeth1061. Epub 2007 Jun 24.
5
Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?过氧化物酶体增殖物激活受体γ:癌症治疗的新靶点?
Anticancer Drugs. 2007 Mar;18(3):237-44. doi: 10.1097/CAD.0b013e328011e67d.
6
R5020 and RU486 act as progesterone receptor agonists to enhance Sp1/Sp4-dependent gene transcription by an indirect mechanism.R5020和米非司酮作为孕激素受体激动剂,通过间接机制增强Sp1/Sp4依赖的基因转录。
Mol Endocrinol. 2007 Mar;21(3):635-50. doi: 10.1210/me.2006-0274. Epub 2006 Dec 27.
7
Branching morphogenesis in the prostate gland and seminal vesicles.前列腺和精囊中的分支形态发生。
Differentiation. 2006 Sep;74(7):382-92. doi: 10.1111/j.1432-0436.2006.00101.x.
8
Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins.雄激素通过雷帕霉素哺乳动物靶点激活和细胞周期蛋白D蛋白的转录后增加来诱导前列腺癌细胞增殖。
Cancer Res. 2006 Aug 1;66(15):7783-92. doi: 10.1158/0008-5472.CAN-05-4472.
9
Molecular biology of prostate-cancer pathogenesis.前列腺癌发病机制的分子生物学
Curr Opin Urol. 2006 May;16(3):123-31. doi: 10.1097/01.mou.0000193384.39351.64.
10
C/EBPalpha: a tumour suppressor in multiple tissues?C/EBPα:一种在多种组织中发挥作用的肿瘤抑制因子?
Biochim Biophys Acta. 2006 Aug;1766(1):88-103. doi: 10.1016/j.bbcan.2006.02.003. Epub 2006 Mar 24.